This is insanity. Have been a veteran of small caps for a long time. Own a few here. Given increased volume, suspect offering (which makes no sense, given share buy-back), change in critical management, or bad news at conference. Not just shorting pressure, I don't think.
R
@docoroc Those 2 conferences were very near the end of the trading day yesterday and that's when DCGO saw buyers return. This is a VERY WELL RUN COMPANY whose only problem imo is finding enough staff for all the business they have!
L
Going to double it’s the next $KIND
j
$55 million in revenue over 3 years from a state with just 3 million people. One day people will wake up and realize that this is going to be a major league company. While contracts like this likely mean that the company will be beating analysts' estimates handily, large incremental Covid-related revenues will not last forever. At that point, my bet is that the relationships established with governments now will lead to additional business, as with their current deal with NY City to help people who are underserved, like the homeless. IMO DocGo will eventually be a $1+ billion revenue company.
j
Great Q4 and yearend results today plus a good conference call with lots of interest from analysts at known firms. Outlook for next year is $400-420M Revenue and $35-41M Adjusted EBITDA. On the call they said that the Total Addressable Market (TAM) for their services is over $100B today and growing very rapidly. For those concerned about gas prices, $1 per gallon higher reduces Gross Margin by $1.5M, not material. 100M shares now outstanding and $175M cash. I stick with my view of 2 months ago that DocGo is going to be a major league company with $1+B of revenue.
S
Wow what a futuristic idea! Drs that come to your house! I'm in! Can we pay the doc with a chicken?
F
Why are there 2 listings for DocGo dcgow and dcgo?
m
this company is amazing- it has no debt on its books and it reports earnings 1st week of Dec.-
S
Should start jumping!
M
some stocks are just not good looking even though they make a decent burger
A
https://www.reddit.com/r/MillennialBets/comments/rf1zbb/docgo_dcgo_a_telemedicine_disruptor_royal_pains/ DCGO is one of the best risk/reward in the market whichever way the market turns - A safe haven since defensives/healthcare sectors do well during inflationary, rising interest rate environment If inflation turns out to be tame and growth picks up DCGO will do fine due to their massive growth If this years laggards turn out be winners next year DCGO will rise along with other biotech and telemedicine sector plays such as TDOC, ARKG Could see multiple expansion when market realizes the undervaluation and/or that they are a disruptor in last mile healthcare Continued growth tailwinds from Covid management Analyst actions and guidance increases protect from further downside even if the market turns ugly. Potential acquisition target by a larger telehealth provider such as Teladoc (TDOC) once they realize that Telemedicine is Just Talk while Mobile Health is Hands On
g
expect volatility until Q4 financials are announced in couple months. Management also needs to promote the company to the investment communit such that advisors will begin to pitch the stock to clients. DocGo is a relatively unknowm small cap stock that needs signigicanf efforts to raise its profile. as the investment community decomes more aware, the price will rise.
F
I would think this company is in competition with TDOC. However, big price difference. Any thoughts.
Y
DocGo is up 6.68% to 9.90
Y
DocGo is up 13.72% to 2.57
Y
DocGo is up 6.03% to 9.15
S
Well I'm going to post this just to update this sleeping board.....
DCGO is one of the best risk/reward in the market whichever way the market turns -
A safe haven since defensives/healthcare sectors do well during inflationary, rising interest rate environment
If inflation turns out to be tame and growth picks up DCGO will do fine due to their massive growth
If this years laggards turn out be winners next year DCGO will rise along with other biotech and telemedicine sector plays such as TDOC, ARKG
Could see multiple expansion when market realizes the undervaluation and/or that they are a disruptor in last mile healthcare
Continued growth tailwinds from Covid management
Analyst actions and guidance increases protect from further downside even if the market turns ugly.
Potential acquisition target by a larger telehealth provider such as Teladoc (TDOC) once they realize that Telemedicine is Just Talk while Mobile Health is Hands On